Abstract
There is significant variability amongst transplant centers, Organ Procurement Organizations (OPO), members of public, and patients about organs from Public Health Service increased risk donors. This has therefore required regulatory bodies like Centers for Disease Control and Prevention to formulate policies for transplant centers and OPOs to minimize risk of infectious transmission to recipients of solid-organ transplants from such donors.
Original language | English (US) |
---|---|
Pages (from-to) | 9-12 |
Number of pages | 4 |
Journal | Experimental and Clinical Transplantation |
Volume | 13 |
DOIs | |
State | Published - Jul 23 2015 |
Keywords
- Antibody test
- Hepatitis B virus
- Hepatitis C virus
- Human immunodeficiency virus
- Nucleic acid test
- Outcomes
- Survival
ASJC Scopus subject areas
- Transplantation